The number of doses per container (DPC) can impact the ability to efficiently achieve a country’s goals for timely and equitable coverage, and also has implications for safety, costs, supply chain, and wastage. Given the complexity associated with trade-offs between price and immunization coverage and other system components, it is important that immunization stakeholders understand the evidence to support the DPC decision. This resource is a culmination of Dose Per Container Partnership (DPCP) research results to provide decision-makers with evidence that can be generalized to other countries when considering vaccine presentation. This resource was developed by JSI in 2020.
We strive to build lasting relationships to produce better health outcomes for all.
